Publications by authors named "Maxine Gowen"

Claim this Profile
U
US immigration order strikes against biotech.
Jeremy M Levin, Steven H Holtzman, John Maraganore, Paul J Hastings, Ron Cohen, Maxine Gowen

Nat Biotechnol· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selectively engaging β-arrestins at the angiotensin II type 1 receptor reduces blood pressure and increases cardiac performance.
Jonathan D Violin, Scott M DeWire, Dennis Yamashita, David H Rominger, Lisa Nguyen, Maxine Gowen

J Pharmacol Exp Ther· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An orally active calcium-sensing receptor antagonist that transiently increases plasma concentrations of PTH and stimulates bone formation.
Sanjay Kumar, Christopher J Matheny, Sandra J Hoffman, Robert W Marquis, Maggie Schultz, Maxine Gowen

Bone· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antagonists of the calcium receptor. 2. Amino alcohol-based parathyroid hormone secretagogues.
Robert W Marquis, Amparo M Lago, James F Callahan, Attiq Rahman, Xiaoyang Dong, Maxine Gowen

J Med Chem· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antagonists of the calcium receptor I. Amino alcohol-based parathyroid hormone secretagogues.
Robert W Marquis, Amparo M Lago, James F Callahan, Robert E Lee Trout, Maxine Gowen

J Med Chem· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An azepanone-based inhibitor of human cathepsin K with improved oral bioavailability in the rat and the monkey.
Robert W Marquis, Keith W Ward, Theresa Roethke, Brian R Smith, Yu Ru, Maxine Gowen

Mol Pharm· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid inhibition of thyroxine-induced bone resorption in the rat by an orally active vitronectin receptor antagonist.
Sandra J Hoffman, Janice Vasko-Moser, William H Miller, Michael W Lark, Maxine Gowen

J Pharmacol Exp Ther· July 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis